Veterinary Medicines

Benazecare Flavour 20 mg Tablets for Dogs

Authorised
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
Benazecare Flavour 20 mg Tablets for Dogs
Benazecare Flavour 20 mg Tablets for Dogs
Active substance:
  • Benazepril hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    20.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Available in:
  • United Kingdom (Northern Ireland)
Package description:
  • Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 14 tablets
  • Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 28 tablets
  • Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 56 tablets
  • Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 140 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 32742/4037
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0452/002
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/07/2025
Download

Combined File of all Documents

English (PDF)
Published on: 6/07/2025
Download